| Literature DB >> 28920919 |
Chunhua Dai1, Yan Hang2, Alena Shostak1, Greg Poffenberger1, Nathaniel Hart1, Nripesh Prasad3, Neil Phillips1, Shawn E Levy3, Dale L Greiner4, Leonard D Shultz5, Rita Bottino6, Seung K Kim2,7, Alvin C Powers1,8,9.
Abstract
Inadequate pancreatic β cell function underlies type 1 and type 2 diabetes mellitus. Strategies to expand functional cells have focused on discovering and controlling mechanisms that limit the proliferation of human β cells. Here, we developed an engraftment strategy to examine age-associated human islet cell replication competence and reveal mechanisms underlying age-dependent decline of β cell proliferation in human islets. We found that exendin-4 (Ex-4), an agonist of the glucagon-like peptide 1 receptor (GLP-1R), stimulates human β cell proliferation in juvenile but not adult islets. This age-dependent responsiveness does not reflect loss of GLP-1R signaling in adult islets, since Ex-4 treatment stimulated insulin secretion by both juvenile and adult human β cells. We show that the mitogenic effect of Ex-4 requires calcineurin/nuclear factor of activated T cells (NFAT) signaling. In juvenile islets, Ex-4 induced expression of calcineurin/NFAT signaling components as well as target genes for proliferation-promoting factors, including NFATC1, FOXM1, and CCNA1. By contrast, expression of these factors in adult islet β cells was not affected by Ex-4 exposure. These studies reveal age-dependent signaling mechanisms regulating human β cell proliferation, and identify elements that could be adapted for therapeutic expansion of human β cells.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28920919 PMCID: PMC5617654 DOI: 10.1172/JCI91761
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808